ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2300

Activation of Tissue-Resident T Cells in Sjögren’s Disease with Human Salivary Organoids

Brandon Law1, Rahmatullah Rahmati2 and Andrew Luster3, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts Eye & Ear, Boston, MA, 3Massachusetts General Hospital, Charlestown, MA

Meeting: ACR Convergence 2024

Keywords: Sjögren's syndrome, T Cell, Tissue Engineering

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Sjögren's Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s disease (SjD) is a chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands, particularly the salivary glands. These focal lymphocytic infiltrates are typically dominated by heterogeneous populations of T cells, including CD4+ and CD8+ T cells, as well as unconventional double-negative (DN) T cells that lack CD4 and CD8. DN T cells have been associated with higher inflammatory activity,1-2 but whether they participate directly in glandular dysfunction is unknown. Identifying activated in situ T cells from this heterogeneous cell population is crucial for elucidating SjD mechanisms and identifying therapeutic targets. In this study, we investigate the activation and function of salivary gland T cells in a co-culture model with salivary gland organoids.

Methods: Cryopreserved salivary gland biopsies from SjD patients were thawed and cultured to develop human salivary organoids. Salivary organoids and salivary T cells were cultured as distinct populations and also in co-culture in serum-free, defined conditions containing growth factors. T cell phenotypes were analyzed using flow cytometry and immunofluorescence, focusing on activation state, degranulation, cytokine production, and cytotoxicity.

Results: Whereas long-term T cell culture preserved distinct CD4, CD8, and DN T cell populations, co-culture with salivary organoids led to a relative increase in the DN T cell population. Some DN T cells expressed activation-induced markers CD25 and ICOS, suggesting antigen-specific activation. These cells showed significant cytokine production, including IFNγ and IL-17A, with some cells being polyfunctional, producing both IFNγ and IL-17A. Organoid-stimulated T cells also expressed CD107a, a marker of degranulation, and produced granzyme B, indicating cytotoxic activity.

Conclusion: This novel model using human salivary organoid and T cell co-culture from patient-derived samples in  defined conditions provides a valuable tool for studying factors that drive tissue T cell activation in SjD. Our findings highlight the significant role of salivary gland T cells, including the unconventional DN T cell population, in glandular damage and offer new insights into the cellular mechanisms driving SjD.

References 

1.     Alunno, Alessia, et al. “IL-17-producing CD4− CD8− T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren’s syndrome.” Annals of the rheumatic diseases 72.2 (2013): 286-292
2.     Alunno, Alessia, et al. “CD4− CD8− T-cells in primary Sjögren’s syndrome: association with the extent of glandular involvement.” Journal of autoimmunity 51 (2014): 38-43.


Disclosures: B. Law: None; R. Rahmati: None; A. Luster: None.

To cite this abstract in AMA style:

Law B, Rahmati R, Luster A. Activation of Tissue-Resident T Cells in Sjögren’s Disease with Human Salivary Organoids [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/activation-of-tissue-resident-t-cells-in-sjogrens-disease-with-human-salivary-organoids/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activation-of-tissue-resident-t-cells-in-sjogrens-disease-with-human-salivary-organoids/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology